Brain wave monitor may reduce sedative use in heart surgery ICU patients

NCT ID NCT07350122

Not yet recruiting Symptom relief Sponsor: Medical University of Graz Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether using a special brain monitor (BIS) to guide sedation can reduce the amount of sedative drugs given to adults in the ICU after heart surgery. About 144 participants will be randomly assigned to either BIS-guided sedation or standard care. The goal is to see if this approach leads to faster recovery and fewer complications like pneumonia or delirium.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Bispectral Index (BIS) monitor
What this could lead to: If it works, this could lead to safer sedation practices for heart surgery patients in the ICU, potentially reducing time on a ventilator and complications like pneumonia or delirium.
What could go wrong: This is a small, early-stage trial with only 144 participants, so results may not apply to all patients. The benefit of BIS monitoring over standard care is unproven, and there is a risk of no significant improvement.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARDIAC SURGICAL PROCEDURES (POSTOPERATIVE POPULATION) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Critical Illness delirium Emergence Delirium Pneumonia, Ventilator-Associated Postoperative Complications

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CARDIAC SURGICAL PROCEDURES (POSTOPERATIVE POPULATION) CRITICAL ILLNESS DELIRIUM - POSTOPERATIVE PNEUMONIA, VENTILATOR-ASSOCIATED POSTOPERATIVE COMPLICATIONS (CARDIOPULMONARY)

More trials for these conditions

Other studies related to the condition(s) this trial covers.